Elyxium Wealth’s Zimmer Biomet ZBH Stock Holding History

Elyxium Wealth’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-227	Closed	-$20.4K	–	1299
2025 Q4	$20.4K	Buy	+227	New	+$21.5K	0.01%	585

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elyxium Wealth's ZBH Position: Q1 2026 in Review

Elyxium Wealth sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 227 shares — an estimated $20.4K sold.

Elyxium Wealth first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $20.4K in Q4 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Elyxium Wealth reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Elyxium Wealth sold 227 Zimmer Biomet shares in Q1 2026, an estimated $20.4K.
Elyxium Wealth first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
Elyxium Wealth's Zimmer Biomet position peaked at $20.4K in Q4 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.